The ROE (Return on Equity) of Lineage Cell Therapeutics Inc (LCTX) is -23.74%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -23.74% |
| 2023-12-31 | -33.88% |
| 2022-12-31 | -35.84% |
| 2021-12-31 | -46.66% |
| 2020-12-31 | -21.47% |
| 2019-12-31 | -10.36% |
| 2018-12-31 | -49.03% |
| 2017-12-31 | -12.29% |
| 2016-12-31 | 28.47% |
| 2015-12-31 | -174.68% |